Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape. Actualité hématologique au Canada, Toronto, Canada, v. 5, n. 1, p. 24–35, 2026. DOI: 10.58931/cht.2026.5185. Disponível em: https://canadianhematologytoday.com/article/view/5-1-Latscha_et_al. Acesso em: 10 juin. 2026.